Measurement of Cancer-Related Risk Perception in Smokers

Survey Clinical Trial

Official title:

Measurement of Cancer-Related Risk Perception in Smokers

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00588211
• Other study ID #: 01-121
• Secondary ID: CA93182
• Status: Completed
• Start date: September 2001
• Est. completion date: September 13, 2022

Study information

• Verified date: September 2022
• Source: Memorial Sloan Kettering Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to develop an accurate way of measuring people's thoughts about cancer risk. The researchers at the Queens Hospital Center, Memorial Sloan-Kettering Cancer Center and Adelphi University are working together to design a new measure. Findings from this study will help us find new ways to help people avoid cancer.

Description:

The goal of the study is to develop and provide initial evidence for the reliability and validity of a measure of cancer-related risk perception. As such, the primary outcomes of the study will be initial construct validity (convergent validity and discriminant validity) of the proposed scale as evidenced by correlations of this test with other tests that vary in the degree of association to the proposed construct of cancer-related risk perception. It is anticipated that the cancer-related risk perception scale will correlate most highly (.50-.60) with measures of tobacco and environmental risk exposures, readiness to quit smoking, and family cancer history.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1514
• Est. completion date: September 13, 2022
• Est. primary completion date: September 13, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Subject must be >= to 18 years of age
• For recruitment at Adelphi University: Speak English
• For recruitment at Queens Hospital Center: Speak English
• For recruitment at Queens Hospital Center: Must be a Queens Hospital Center Patient

Exclusion Criteria:

• Patients who have a history of colorectal cancer at the Queens Hospital Center
• Patients who cannot give informed consent

Related Conditions & MeSH terms

• Cancer Related-Risks
• Focus Group
• Risk Perception
• Survey

Intervention

Behavioral:
• Interviews
45-minute individual interviews after the conclusion of their dental appointment
• focus group
A focus group of the preliminary cancer-related risk perception item pool.
• Survey
Quantitative item analysis of the final item pool.
• Survey
A second confirmatory factor analysis.

Locations

Country	Name	City	State
United States	Queens Hospital Center	Jamaica	New York
United States	Adelphi University	New York	New York
United States	Memorial Sloan-Kettering Cancer Center	New York	New York
United States	New York University, College of Dentistry	New York	New York

Sponsors (4)

Lead Sponsor	Collaborator
Memorial Sloan Kettering Cancer Center	Adelphi University, National Cancer Institute (NCI), Queen's Hospital Center

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Develop a comprehensive "blueprint," or description of the cancer-related risk perception construct; to use it to generate a cancer-related risk perception item pool; conduct an analysis of the generated items		3 years
Secondary	to establish initial evidence for scale reliability and validity		3 years

External Links

•   Memorial Sloan-Kettering web site